Back
Amylyx Pharmaceuticals Vs. Cassava Sciences Industry Stock Comparison
Sell
41
AMLX
Amylyx Pharmaceuticals
Last Price:
1.85
Seasonality Move:
23.82%
Sell
26
SAVA
Cassava Sciences
Last Price:
19.27
Seasonality Move:
3.78%
Sell
41
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy, Sell or Hold?
- The current Amylyx Pharmaceuticals [AMLX] share price is $1.84. The Score for AMLX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- AMLX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $19.80. The Score for SAVA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- SAVA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMLX Stock Price Chart
What is Amylyx Pharmaceuticals's stock price today?
-
The Amylyx Pharmaceuticals share price today is $1.84
The current trend is relatively stagnant and AMLX is experiencing slight selling pressure.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $19.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing slight selling pressure.
AMLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 50.7 | Buy |
| Chaikin Money Flow: | -418439 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.67 - 1.79) | Buy |
| Bollinger Bands (100): | (-0.53 - 12.53) | Sell |
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.51 | Sell |
| Relative Strength Index (14 RSI): | 43.79 | Sell |
| Chaikin Money Flow: | -371890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.55 - 22.03) | Sell |
| Bollinger Bands (100): | (19.99 - 23.35) | Sell |
AMLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.7 | Buy |
| 20-day SMA: | 1.71 | Buy |
| 50-day SMA: | 1.83 | Buy |
| 200-day SMA: | 11.03 | Sell |
| 8-day EMA: | 1.73 | Buy |
| 20-day EMA: | 1.75 | Buy |
| 50-day EMA: | 2.63 | Sell |
| 200-day EMA: | 10.11 | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.74 | Buy |
| 20-day SMA: | 20.41 | Sell |
| 50-day SMA: | 21.14 | Sell |
| 200-day SMA: | 21.56 | Sell |
| 8-day EMA: | 19.85 | Sell |
| 20-day EMA: | 20.29 | Sell |
| 50-day EMA: | 20.98 | Sell |
| 200-day EMA: | 22.13 | Sell |
Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.09 per share, an increase next quarter of $0.14 per share, a decrease this year of $3.95 per share, and an increase next year of $1.35 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $1.37 per share.
Amylyx Pharmaceuticals Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cassava Sciences Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||